Literature DB >> 23512691

Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.

Farid Saad1, Ahmad Haider, Gheorghe Doros, Abdulmaged Traish.   

Abstract

OBJECTIVE: This study analyzed the effects of normalization of serum testosterone (T) levels on anthropometric parameters in hypogonadal men. DESIGN AND METHODS: Open-label, single-center, cumulative, prospective registry study of 255 men (aged 33-69 years, mean 58.02 ± 6.30 years), with T levels below 12.13 nmol/L (mean: 9.93±1.38). 215 men for at least 2 years, 182 for 3 years, 148 for 4, and 116 for at least 5 years were studied. They received parenteral T undecanoate 1,000 mg/12 weeks after an initial interval of 6 weeks.
RESULTS: Body weight (BW) decreased from 106.22 ± 16.93 kg to 90.07 ± 9.51 kg. Waist circumference (WC) reduced from 107.24 ± 9.14 cm to 98.46 ± 7.39 cm. BMI (m/kg(2) ) declined from 33.9 ± 5.51 m/kg(2) to 29.13 ± 3.09 m/kg(2) . All parameters examined were statistically significant with P < 0.0001 versus baseline and versus the previous year over 5 years indicating a continuous weight loss over the full observation period. The mean per cent weight loss after 1 year was 4.16 ± 0.31%, after 2 years 7.54 ± 0.32%, after 3 years 9.23 ± 0.33%, after 4 years 11.42 ± 0.35% and after 5 years 13.57 ± 0.37%.
CONCLUSIONS: In an uncontrolled, observational cohort, normalizing serum T to normal physiological levels produced consistent loss of BW, WC, and BMI. These improvements were progressive over the full 5 years of the study.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512691     DOI: 10.1002/oby.20407

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  35 in total

Review 1.  Testosterone supplementation and body composition: results from a meta-analysis of observational studies.

Authors:  G Corona; V A Giagulli; E Maseroli; L Vignozzi; A Aversa; M Zitzmann; F Saad; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-05-30       Impact factor: 4.256

Review 2.  Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.

Authors:  Jason R Kovac; Jason Kovac; Alexander W Pastuszak; Dolores J Lamb; Larry I Lipshultz
Journal:  Postgrad Med       Date:  2014-11       Impact factor: 3.840

Review 3.  Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?

Authors:  Dimitri C Cassimatis; Matthew T Crim; Nanette K Wenger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-12

Review 4.  The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Authors:  Abdulmaged M Traish; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

5.  Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.

Authors:  Jason R Kovac; Saneal Rajanahally; Ryan P Smith; Robert M Coward; Dolores J Lamb; Larry I Lipshultz
Journal:  J Sex Med       Date:  2013-11-06       Impact factor: 3.802

Review 6.  [The "obese" and "old" male patient in dermatological practice. When should hypogonadism be considered?].

Authors:  D Varwig-Janßen; F Ochsendorf
Journal:  Hautarzt       Date:  2015-12       Impact factor: 0.751

7.  Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.

Authors:  Robert S Tan; Kelly R Cook; William G Reilly
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

8.  Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model.

Authors:  Amr Abdelhamed; Shin-Ichi Hisasue; Masato Shirai; Kazuhito Matsushita; Yoshiaki Wakumoto; Akira Tsujimura; Taiji Tsukamoto; Shigeo Horie
Journal:  Res Rep Urol       Date:  2015-03-05

9.  Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss.

Authors:  Aa Yassin; G Doros
Journal:  Clin Obes       Date:  2013-06-19

Review 10.  Risks and benefits of late onset hypogonadism treatment: an expert opinion.

Authors:  Giovanni Corona; Linda Vignozzi; Alessandra Sforza; Mario Maggi
Journal:  World J Mens Health       Date:  2013-08-31       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.